Matthew Lipman

Track

Insider profile

Currently holds positions in Soluna Holdings Inc and Capstone Therapeutics Corp

Positions

Position Company Period
Director Soluna Holdings Inc Oct. 21, 2016 -
Director Capstone Therapeutics Corp July 14, 2017 -
Matthew Lipman's trades of Capstone Therapeutics Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2025-03-07
B Purchase
63,822 +14.6%
254.58
US$1,944,170 		63,822 +14.6% 254.58 US$1,944,170
2024-12-10 2024-12-09
S Sale
73,000 +18.1%
143.90
US$568,599 		73,000 +18.1% 143.90 US$568,599
2024-12-10 2024-12-06
S Sale
13,147 +13.5%
56.11
US$452,846 		13,147 +13.5% 56.11 US$452,846
2024-12-10 2024-12-06
S Sale
100 -0.4%
11.20
US$1,120 		100 -0.4% 11.20 US$1,120
2024-11-12 2024-11-11
PlS Planned sale
9,080 -100.0%
4.00
US$36,320 		9,080 -100.0% 4.00 US$36,320
2024-11-12 2024-11-08
PlS Planned sale
21,900 -70.7%
3.42
US$74,898 		21,900 -70.7% 3.42 US$74,898
2024-11-07 2024-11-07
PlS Planned sale
24,420 -44.1%
3.59
US$87,668 		24,420 -44.1% 3.59 US$87,668
2024-11-07 2024-11-06
PlS Planned sale
23,700 -30.0%
3.56
US$84,372 		23,700 -30.0% 3.56 US$84,372
2024-11-07 2024-11-05
PlS Planned sale
11,000 -12.2%
3.23
US$35,530 		11,000 -12.2% 3.23 US$35,530
2025-03-28 2024-11-04
PlS Planned sale
20,600 -18.6%
3.11
US$64,066 		20,600 -18.6% 3.11 US$64,066
2025-03-28 2024-11-01
PlS Planned sale
31,300 -22.0%
3.39
US$106,107 		31,300 -22.0% 3.39 US$106,107
2025-03-28 2024-10-31
PlS Planned sale
8,000 -5.3%
3.44
US$27,520 		8,000 -5.3% 3.44 US$27,520